 | • レポートコード：B-GIR09F3111 • 出版社/出版日：GlobalInfoResearch / 2019年10月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ハンター症候群治療の世界市場について調べ、まとめました。種類別セグメントは、酵素補充療法（ERT）、造血幹細胞移植（HSCT）、その他等、用途別セグメントは、ライフサイエンス企業、研究所、病院等に区分しました。ハンター症候群治療の世界市場概観、企業動向、企業別ハンター症候群治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ハンター症候群治療の市場概観 ・ハンター症候群治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ハンター症候群治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・ハンター症候群治療の世界市場規模 ・ハンター症候群治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・ハンター症候群治療のアメリカ市場規模推移 ・ハンター症候群治療のカナダ市場規模推移 ・ハンター症候群治療のメキシコ市場規模推移 ・ハンター症候群治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ハンター症候群治療のドイツ市場規模推移 ・ハンター症候群治療のイギリス市場規模推移 ・ハンター症候群治療のロシア市場規模推移 ・ハンター症候群治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ハンター症候群治療の日本市場規模推移 ・ハンター症候群治療の中国市場規模推移 ・ハンター症候群治療の韓国市場規模推移 ・ハンター症候群治療のインド市場規模推移 ・ハンター症候群治療の東南アジア市場規模推移 ・ハンター症候群治療の南米市場分析（ブラジル、アルゼンチン等） ・ハンター症候群治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ハンター症候群治療の種類別分析/販売量、売上、市場シェア（酵素補充療法（ERT）、造血幹細胞移植（HSCT）、その他） ・ハンター症候群治療の用途別分析/市場規模（ライフサイエンス企業、研究所、病院） ・ハンター症候群治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ハンター症候群治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Hunter Syndrome Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hunter Syndrome Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Hunter Syndrome Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hunter Syndrome Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Inventiva S.A.
Denali Therapeutics Inc.
RegenxBio Inc.
GC Pharma.
Shire Plc.
JCR Pharmaceuticals Co Ltd.
Esteve.
ArmaGen Inc.
Sangamo Therapeutics, Inc.
Bioasis Technologies Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Enzyme Replacement Therapy (ERT)
Hematopoietic Stem Cell Transplant (HSCT)
Others
Market Segment by Applications, can be divided into
Life Science Companies
Research Institutes
Hospital
Table of Contents
1 Hunter Syndrome Treatment Market Overview
1.1 Product Overview and Scope of Hunter Syndrome Treatment
1.2 Classification of Hunter Syndrome Treatment by Types
1.2.1 Global Hunter Syndrome Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Hunter Syndrome Treatment Revenue Market Share by Types in 2018
1.2.3 Enzyme Replacement Therapy (ERT)
1.2.4 Hematopoietic Stem Cell Transplant (HSCT)
1.2.5 Others
1.3 Global Hunter Syndrome Treatment Market by Application
1.3.1 Global Hunter Syndrome Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Life Science Companies
1.3.3 Research Institutes
1.3.4 Hospital
1.4 Global Hunter Syndrome Treatment Market by Regions
1.4.1 Global Hunter Syndrome Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Hunter Syndrome Treatment (2014-2024)
2 Company Profiles
2.1 Inventiva S.A.
2.1.1 Business Overview
2.1.2 Hunter Syndrome Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Inventiva S.A. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Denali Therapeutics Inc.
2.2.1 Business Overview
2.2.2 Hunter Syndrome Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Denali Therapeutics Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 RegenxBio Inc.
2.3.1 Business Overview
2.3.2 Hunter Syndrome Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 RegenxBio Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 GC Pharma.
2.4.1 Business Overview
2.4.2 Hunter Syndrome Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GC Pharma. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Shire Plc.
2.5.1 Business Overview
2.5.2 Hunter Syndrome Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Shire Plc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 JCR Pharmaceuticals Co Ltd.
2.6.1 Business Overview
2.6.2 Hunter Syndrome Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 JCR Pharmaceuticals Co Ltd. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Esteve.
2.7.1 Business Overview
2.7.2 Hunter Syndrome Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Esteve. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 ArmaGen Inc.
2.8.1 Business Overview
2.8.2 Hunter Syndrome Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 ArmaGen Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sangamo Therapeutics, Inc.
2.9.1 Business Overview
2.9.2 Hunter Syndrome Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sangamo Therapeutics, Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Bioasis Technologies Inc.
2.10.1 Business Overview
2.10.2 Hunter Syndrome Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bioasis Technologies Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Hunter Syndrome Treatment Market Competition, by Players
3.1 Global Hunter Syndrome Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Hunter Syndrome Treatment Players Market Share
3.2.2 Top 10 Hunter Syndrome Treatment Players Market Share
3.3 Market Competition Trend
4 Global Hunter Syndrome Treatment Market Size by Regions
4.1 Global Hunter Syndrome Treatment Revenue and Market Share by Regions
4.2 North America Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
5 North America Hunter Syndrome Treatment Revenue by Countries
5.1 North America Hunter Syndrome Treatment Revenue by Countries (2014-2019)
5.2 USA Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6 Europe Hunter Syndrome Treatment Revenue by Countries
6.1 Europe Hunter Syndrome Treatment Revenue by Countries (2014-2019)
6.2 Germany Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6.4 France Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Hunter Syndrome Treatment Revenue by Countries
7.1 Asia-Pacific Hunter Syndrome Treatment Revenue by Countries (2014-2019)
7.2 China Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7.5 India Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
8 South America Hunter Syndrome Treatment Revenue by Countries
8.1 South America Hunter Syndrome Treatment Revenue by Countries (2014-2019)
8.2 Brazil Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Hunter Syndrome Treatment by Countries
9.1 Middle East and Africa Hunter Syndrome Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
10 Global Hunter Syndrome Treatment Market Segment by Type
10.1 Global Hunter Syndrome Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Hunter Syndrome Treatment Market Forecast by Type (2019-2024)
10.3 Enzyme Replacement Therapy (ERT) Revenue Growth Rate (2014-2024)
10.4 Hematopoietic Stem Cell Transplant (HSCT) Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Hunter Syndrome Treatment Market Segment by Application
11.1 Global Hunter Syndrome Treatment Revenue Market Share by Application (2014-2019)
11.2 Hunter Syndrome Treatment Market Forecast by Application (2019-2024)
11.3 Life Science Companies Revenue Growth (2014-2019)
11.4 Research Institutes Revenue Growth (2014-2019)
11.5 Hospital Revenue Growth (2014-2019)
12 Global Hunter Syndrome Treatment Market Size Forecast (2019-2024)
12.1 Global Hunter Syndrome Treatment Market Size Forecast (2019-2024)
12.2 Global Hunter Syndrome Treatment Market Forecast by Regions (2019-2024)
12.3 North America Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
12.6 South America Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Hunter Syndrome Treatment Picture
Table Product Specifications of Hunter Syndrome Treatment
Table Global Hunter Syndrome Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Hunter Syndrome Treatment Revenue Market Share by Types in 2018
Figure Enzyme Replacement Therapy (ERT) Picture
Figure Hematopoietic Stem Cell Transplant (HSCT) Picture
Figure Others Picture
Table Global Hunter Syndrome Treatment Revenue (Million USD) by Application (2014-2024)
Figure Hunter Syndrome Treatment Revenue Market Share by Applications in 2018
Figure Life Science Companies Picture
Figure Research Institutes Picture
Figure Hospital Picture
Table Global Market Hunter Syndrome Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Inventiva S.A. Basic Information, Manufacturing Base and Competitors
Table Inventiva S.A. Hunter Syndrome Treatment Type and Applications
Table Inventiva S.A. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Denali Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table Denali Therapeutics Inc. Hunter Syndrome Treatment Type and Applications
Table Denali Therapeutics Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table RegenxBio Inc. Basic Information, Manufacturing Base and Competitors
Table RegenxBio Inc. Hunter Syndrome Treatment Type and Applications
Table RegenxBio Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GC Pharma. Basic Information, Manufacturing Base and Competitors
Table GC Pharma. Hunter Syndrome Treatment Type and Applications
Table GC Pharma. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Plc. Basic Information, Manufacturing Base and Competitors
Table Shire Plc. Hunter Syndrome Treatment Type and Applications
Table Shire Plc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table JCR Pharmaceuticals Co Ltd. Basic Information, Manufacturing Base and Competitors
Table JCR Pharmaceuticals Co Ltd. Hunter Syndrome Treatment Type and Applications
Table JCR Pharmaceuticals Co Ltd. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Esteve. Basic Information, Manufacturing Base and Competitors
Table Esteve. Hunter Syndrome Treatment Type and Applications
Table Esteve. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table ArmaGen Inc. Basic Information, Manufacturing Base and Competitors
Table ArmaGen Inc. Hunter Syndrome Treatment Type and Applications
Table ArmaGen Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sangamo Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics, Inc. Hunter Syndrome Treatment Type and Applications
Table Sangamo Therapeutics, Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bioasis Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table Bioasis Technologies Inc. Hunter Syndrome Treatment Type and Applications
Table Bioasis Technologies Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Hunter Syndrome Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Hunter Syndrome Treatment Revenue Share by Players (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Players in 2017
Figure Global Hunter Syndrome Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Hunter Syndrome Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Hunter Syndrome Treatment Revenue Market Share in 2018
Figure Global Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Hunter Syndrome Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Hunter Syndrome Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Market Share by Regions in 2018
Figure North America Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure South America Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table North America Hunter Syndrome Treatment Revenue by Countries (2014-2019)
Table North America Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure USA Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table Europe Hunter Syndrome Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure Germany Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure UK Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure France Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Hunter Syndrome Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure China Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure India Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table South America Hunter Syndrome Treatment Revenue by Countries (2014-2019)
Table South America Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure Brazil Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Hunter Syndrome Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table Global Hunter Syndrome Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Hunter Syndrome Treatment Revenue Share by Type (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Type (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Type in 2018
Table Global Hunter Syndrome Treatment Revenue Forecast by Type (2019-2024)
Figure Global Hunter Syndrome Treatment Market Share Forecast by Type (2019-2024)
Figure Global Enzyme Replacement Therapy (ERT) Revenue Growth Rate (2014-2019)
Figure Global Hematopoietic Stem Cell Transplant (HSCT) Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Hunter Syndrome Treatment Revenue by Application (2014-2019)
Table Global Hunter Syndrome Treatment Revenue Share by Application (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Application (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Application in 2018
Table Global Hunter Syndrome Treatment Revenue Forecast by Application (2019-2024)
Figure Global Hunter Syndrome Treatment Market Share Forecast by Application (2019-2024)
Figure Global Life Science Companies Revenue Growth Rate (2014-2019)
Figure Global Research Institutes Revenue Growth Rate (2014-2019)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Hunter Syndrome Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Hunter Syndrome Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
Figure Europe Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
Figure South America Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
世界のダンピング症候群治療市場予測（～2024年） Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping…- 世界のQT延長症候群治療市場予測（～2024年） Long QT syndrome is a condition which affects repolarization of the heart after a heartbeat. This results in an increased risk of an irregular heartbeat which can result in palpitations, fainting, drowning, or sudden death. These episodes can be triggered by exercise or stress. Other associated symp…
- 世界のクリッペルトレノー症候群治療市場予測（～2024年） Klippel–Trenaunay Syndrome (KTS or KT) is a rare congenital medical condition in which blood vessels and/or lymph vessels fail to form properly. The three main features are nevus flammeus (port-wine stain), venous and lymphatic malformations, and soft-tissue hypertrophy of the affected limb. It is s…
- 世界のセロトニン症候群治療市場予測（～2024年） Serotonin syndrome refers to a group of symptoms and signs caused by the hyperfunction of serotonin in the nervous system, which is manifested as the triad of cognitive function/behavior change, neuromuscular abnormality and autonomic nervous instability. Scope of the Report: The global Serotonin Sy…
- 反すう症候群治療市場：世界及び中国市場分析・予測（～2024年） Rumination Syndrome Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Rumination Syndrome Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rumination…